Emorivir 200Mg - Anti-COVID Generic Drug Molnupiravir

Emorivir 200Mg - Anti-COVID Generic Drug Molnupiravir

Enquiry Now


Description

Emorivir 200Mg - Anti-COVID Generic Drug Molnupiravir

Molnupiravir is the world’s first oral pill to treat symptomatic COVID-19 which was approved by the UK’s Medicines and Healthcare products Regulatory Agency on 4 November 2021. Molnupiravir is originally developed by the US based pharma major Merck, Sharp & Dohme (MSD) and Ridgeback Biotherapeutics. Beximco Pharma’s branded generic version of molnupiravir will be marketed as Emorivir. Availability of generic molnupiravir will help broaden access and affordability of COVID-19 treatment, especially in low and middle income countries where access to vaccines has been limited.

Available to order now

Inbox us or

Mobile / WhatsApp : +44 7887 477007
Email : info@premiameds.com

Additional Information


You May Also Like...

TESTIMONIALS